Melissa A. Cadnapaphornchai

Pediatric Nephrology

1012 Laurel Oak Rd
Voorhees, NJ 08043

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 40 publications

KDIGO 2025 ADPKD guideline through pediatric eyes.

KDIGO 2025 ADPKD guideline through pediatric eyes.

Journal: Pediatric nephrology (Berlin, Germany)

Published: November 05, 2025

A randomized controlled trial evaluated the effect of pravastatin on kidney disease outcomes in adult patients with early-stage autosomal dominant polycystic kidney disease.

A randomized controlled trial evaluated the effect of pravastatin on kidney disease outcomes in adult patients with early-stage autosomal dominant polycystic kidney disease.

Journal: Kidney international

Published: April 21, 2025

Monitoring of Allograft Adaptation After Kidney Transplantation in Pediatric Patients by Targeted Plasma Metabolomics.

Monitoring of Allograft Adaptation After Kidney Transplantation in Pediatric Patients by Targeted Plasma Metabolomics.

Journal: International journal of molecular sciences

Published: April 04, 2025

Polycystic Kidney Disease in Children: The Current Status and the Next Horizon.

Polycystic Kidney Disease in Children: The Current Status and the Next Horizon.

Journal: American journal of kidney diseases : the official journal of the National Kidney Foundation

Published: September 28, 2024

KDIGO 2025 clinical practice guideline for the evaluation, management, and treatment of autosomal dominant polycystic kidney disease (ADPKD): executive summary.

KDIGO 2025 clinical practice guideline for the evaluation, management, and treatment of autosomal dominant polycystic kidney disease (ADPKD): executive summary.

Journal: Kidney international

Published: June 14, 2024

Statin therapy in patients with early-stage autosomal dominant polycystic kidney disease: Design and baseline characteristics.

Statin therapy in patients with early-stage autosomal dominant polycystic kidney disease: Design and baseline characteristics.

Journal: Contemporary clinical trials

Published: September 06, 2023

Estimating risk of rapid disease progression in pediatric patients with autosomal dominant polycystic kidney disease: a randomized trial of tolvaptan.

Estimating risk of rapid disease progression in pediatric patients with autosomal dominant polycystic kidney disease: a randomized trial of tolvaptan.

Journal: Pediatric nephrology (Berlin, Germany)

Published: July 11, 2023

Imaging Biomarkers in Young Patients With ADPKD.

Imaging Biomarkers in Young Patients With ADPKD.

Journal: Kidney international reports

Published: February 07, 2023

Hypertension in young adults with autosomal dominant polycystic kidney disease: a case for early screening?

Hypertension in young adults with autosomal dominant polycystic kidney disease: a case for early screening?

Journal: Clinical kidney journal

Published: December 21, 2022

Design of two ongoing clinical trials of tolvaptan in the treatment of pediatric patients with autosomal recessive polycystic kidney disease.

Design of two ongoing clinical trials of tolvaptan in the treatment of pediatric patients with autosomal recessive polycystic kidney disease.

Journal: BMC nephrology

Published: September 13, 2022

Tolvaptan for Children and Adolescents with Autosomal Dominant Polycystic Kidney Disease: Randomized Controlled Trial.

Tolvaptan for Children and Adolescents with Autosomal Dominant Polycystic Kidney Disease: Randomized Controlled Trial.

Journal: Clinical journal of the American Society of Nephrology : CJASN

Published: February 07, 2022

Kynurenines in polycystic kidney disease.

Kynurenines in polycystic kidney disease.

Journal: Journal of nephrology

Published: January 20, 2022

Showing 1-12 of 40

Last Updated: 09/26/2026